Sinopharm Group Co. Ltd. (SHTDF)

AI Score

Unlock

2.30

0.15 (6.98%)

At close: Apr 25, 2025, 10:33 AM

Sinopharm Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	598.32B	596.57B	591.69B	591.63B	570.07B	552.15B	546.15B	533.4B	528.38B	521.05B	510.09B	501.77B	482.28B	456.41B	440.19B	427.37B	424.49B	425.27B	406.39B	382.72B	360.76B	344.53B	336.11B	334.06B	318.41B	308.35B	288.85B	269.36B	264.69B	258.39B	251.4B	244.41B	236.1B
Cost of Revenue	550.17B	548.06B	543.1B	542.58B	521.7B	504.71B	500.52B	488.28B	483.54B	477B	466.06B	458.1B	440.04B	416.09B	401.13B	390.08B	387.35B	387.74B	370.52B	348.47B	328.29B	313.3B	305.96B	304.44B	291.36B	282.3B	265.19B	248.07B	243.62B	237.72B	231.14B	224.56B	216.84B
Gross Profit	48.15B	48.51B	48.58B	49.05B	48.36B	47.43B	45.63B	45.12B	44.84B	44.05B	44.04B	43.67B	42.25B	40.32B	39.07B	37.29B	37.14B	37.53B	35.87B	34.25B	32.47B	31.23B	30.16B	29.62B	27.05B	26.05B	23.67B	21.29B	21.07B	20.67B	20.26B	19.85B	19.26B
Operating Income	20.43B	21.06B	21.31B	21.38B	21.31B	21.06B	19.72B	21.42B	21.53B	20.98B	20.42B	20.59B	19.77B	19.1B	18.47B	17.44B	17.56B	18.18B	17.33B	16.54B	15.93B	15.41B	14.39B	14.43B	12.83B	13.12B	11.99B	10.86B	10.69B	10.2B	10.01B	9.81B	9.47B
Interest Income	2.06B	2.16B	2.15B	2.42B	2.35B	2.6B	3.31B	3.16B	3.33B	3.15B	2.82B	2.85B	2.62B	2.7B	2.63B	2.86B	2.74B	2.87B	2.47B	2.18B	2.54B	2.54B	3.07B	3.24B	2.64B	2.4B	2.1B	1.79B	1.78B	1.72B	1.69B	1.66B	1.82B
Pretax Income	19B	19.51B	19B	19.43B	19.05B	18.56B	17.35B	17.29B	17.36B	17B	17.11B	17.1B	16.41B	15.6B	14.67B	13.59B	13.24B	13.76B	13.52B	12.95B	12.74B	12.21B	11.54B	11.71B	10.62B	11.23B	10.22B	9.22B	9.48B	8.92B	8.75B	8.58B	7.75B
Net Income	8.88B	9.05B	8.77B	8.94B	8.69B	8.53B	7.91B	7.87B	7.97B	7.76B	7.93B	7.87B	7.59B	7.19B	6.61B	6.17B	5.92B	6.25B	6.31B	6.01B	6.09B	5.83B	5.52B	5.61B	5.08B	5.57B	5.22B	4.86B	5B	4.64B	4.51B	4.39B	3.9B
Selling & General & Admin	26.69B	26.48B	27.23B	27.16B	26.49B	25.84B	24.2B	24.28B	23.88B	23.66B	24.05B	23.65B	22.94B	21.87B	21.14B	20.43B	20.14B	19.8B	18.86B	18.13B	16.9B	16.24B	15.42B	15.58B	14.42B	13.35B	12.09B	10.84B	10.88B	10.74B	10.51B	10.28B	10.01B
Research & Development	688.63M	713.46M	663.05M	612.65M	578.31M	543.97M	459.65M	375.32M	355.96M	336.59M	307.79M	278.99M	264.4M	249.8M	249.34M	248.88M	254.06M	259.24M	237.11M	214.99M	204.27M	193.56M	118.9M	44.25M	22.12M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	9.36M	9.36M	37.67M	20.68M	20.68M	20.68M	-7.63M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	437.47B	437.22B	64.72B	26.12B	25.89B	25.2B	396.98B	24.67B	24.15B	23.89B	24.11B	23.72B	23.21B	22.02B	21.76B	20.84B	21.16B	20.9B	19.88B	19.12B	17.19B	16.48B	15.55B	14.66B	13.8B	12.42B	11.35B	10.28B	9.81B	10.02B	9.82B	9.61B	9.69B
Interest Expense	n/a	n/a	1.27B	1.27B	1.27B	1.27B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	17.54B	17.47B	17.45B	17.38B	17.06B	16.72B	15.69B	15.61B	15.48B	15.44B	15.95B	15.49B	14.89B	14.14B	13.47B	12.98B	12.77B	12.56B	11.9B	11.46B	10.84B	10.37B	9.94B	9.8B	9.03B	8.37B	7.58B	6.78B	6.71B	6.62B	6.47B	6.32B	6.17B
Cost & Expenses	576.92B	574.55B	569.43B	568.7B	547.59B	529.91B	525.17B	512.96B	507.69B	500.89B	490.16B	481.82B	463.25B	438.11B	422.89B	410.93B	408.51B	408.64B	390.4B	367.59B	345.48B	329.78B	321.51B	319.1B	305.16B	294.72B	276.53B	258.34B	253.43B	247.74B	240.96B	234.17B	226.53B
Income Tax Expense	4.4B	4.5B	4.4B	4.42B	4.32B	4.22B	3.99B	4.03B	4.03B	3.94B	3.79B	3.78B	3.59B	3.5B	3.37B	3.14B	3.1B	3.14B	3.09B	2.97B	2.93B	2.8B	2.63B	2.69B	2.45B	2.56B	2.31B	2.05B	2.12B	2.03B	2B	1.97B	1.8B
Shares Outstanding (Basic)	3.09B	3.14B	3.12B	3.12B	3.12B	3.15B	3.11B	3.13B	3.1B	3.14B	3.11B	3.12B	3.12B	3.48B	2.76B	3.1B	3.12B	3.01B	2.96B	3.01B	2.94B	3.62B	2.36B	3.16B	2.79B	3.17B	3.17B	2.76B	2.76B	2.76B	2.76B	2.78B	2.76B
Shares Outstanding (Diluted)	3.09B	3.14B	3.12B	3.12B	3.12B	3.15B	3.11B	3.13B	3.1B	3.14B	3.1B	3.12B	3.12B	3.48B	2.76B	3.08B	3.12B	2.99B	2.96B	3.01B	2.94B	3.6B	2.36B	3.16B	2.79B	3.18B	3.18B	2.77B	2.77B	2.77B	2.77B	2.78B	2.76B
EPS (Basic)	2.85	2.90	2.81	2.86	2.77	2.72	2.53	2.52	2.56	2.49	2.47	2.54	2.45	2.32	2.23	2.03	1.97	2.10	2.02	2.03	2.02	1.95	1.92	1.80	1.70	1.88	1.82	1.76	1.81	1.68	1.63	1.58	1.40
EPS (Diluted)	2.85	2.90	2.81	2.86	2.77	2.72	2.53	2.52	2.56	2.49	2.47	2.54	2.46	2.33	2.24	2.04	1.97	2.10	2.03	2.04	2.03	1.96	1.92	1.80	1.70	1.88	1.82	1.76	1.81	1.68	1.64	1.60	1.42
EBITDA	19.87B	24.38B	23.34B	23.15B	23.07B	22.79B	22.7B	23.35B	23.42B	22.84B	22.25B	22.41B	21.49B	20.81B	20.17B	19.03B	19.1B	19.61B	18.65B	17.82B	17.18B	16.62B	15.62B	15.7B	14.02B	14.27B	13.03B	11.79B	11.64B	11.13B	10.95B	10.76B	10.38B
EBIT	4.53B	4.53B	11.77B	12.28B	12.28B	12.28B	5.04B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	2.08B	2.06B	2.05B	2.02B	2B	1.98B	1.95B	1.92B	1.89B	1.86B	1.83B	1.81B	1.73B	1.71B	1.7B	1.58B	1.54B	1.43B	1.32B	1.29B	1.25B	1.22B	1.23B	1.28B	1.19B	1.14B	1.04B	930.07M	947.2M	935.96M	941.49M	947.02M	917.18M